Rossby Financial’s Kura Oncology KURA Stock Holding History

Rossby Financial’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-66	Closed	-$724	–	2520
2026 Q2	$724	Hold	66	–	–	﹤0.01%	1967
2026 Q1	$550	Buy	+66	New	+$567	﹤0.01%	2091

Other funds holding KURA

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Alethea Capital Management Mercer Island, Washington $197M AUM 51.86% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Rossby Financial's KURA Position: Q3 2026 in Review

Rossby Financial sold out of Kura Oncology (KURA) in Q3 2026, closing a stake of 66 shares — an estimated $724 sold.

Rossby Financial first reported a position in KURA in Q1 2026 and held it in 2 quarters. The position peaked at $724 in Q2 2026. 164 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

Rossby Financial reported no remaining Kura Oncology position as of Q3 2026 after selling out during the quarter.
Rossby Financial sold 66 Kura Oncology shares in Q3 2026, an estimated $724.
Rossby Financial first reported a position in Kura Oncology in Q1 2026 and held it in 2 quarters.
Rossby Financial's Kura Oncology position peaked at $724 in Q2 2026.
164 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.